Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFXI.L Regulatory News (FXI)

  • There is currently no data for FXI

Trading Update

7 Oct 2013 07:00

RNS Number : 8126P
Fusionex International PLC
07 October 2013
 



For Immediate Release

7 October 2013

 

 

 

Fusionex International plc

("Fusionex", "the Company" or "the Group")

 

Trading Update

 

Fusionex, an award-winning and market leading international software provider specialising in Business Intelligence, Analytics and Big Data, is pleased to provide the following trading update in advance of its results for the year ended 30 September 2013, which will be announced on or before 31 Jan 2014.

 

During the period, management has made good progress delivering the Group's stated growth strategy of broadening Fusionex's geographical reach and continuing to develop its Big Data offerings and capabilities. The Company's business pipeline remains strong with the team continuing to experience significant demand for its products. This on-going demand is further strengthened by increased awareness of Fusionex's brand and product offerings, particularly across Asia Pacific, where Fusionex recently won Microsoft's Asia Pacific Award for Business Intelligence.

 

Fusionex has also secured its first client in Hong Kong, a key business hub and gateway to North Asia (including China) and a region where management believes strong product demand continues to exist. The Group has built a steady sales pipeline over the last few months in Hong Kong (which covers Northern Asia), and Management is therefore confident that it will progressively win more new business from Hong Kong and China.

 

Fusionex's flagship Big Data product, GIANT, is now in advanced stages of testing. Once launched, GIANT will be able to be deployed to either cloud, on-premise or hybrid environments. Fusionex has conducted a number of paid pilots with clients, and full product launch continues to be targeted before the end of calendar year 2013.

 

In addition Fusionex would like to notify shareholders the Company is now subject to the UK Takeover Code. As of 30 September 2013, all UK, Channel Island and Isle of Man incorporated public companies which have securities admitted to trading on AIM will be subject to the Code, irrespective of their place of central management and control.

Management remains confident that a combination of the Group's strong market traction within the Asia Pacific region, significant sales momentum and on-going investment in sales and development teams will continue to generate exciting growth in the medium and long term.

 

The board anticipates that the revenue as well as profit achieved for the full year results for the year ending 30 September will be at least in line with market expectations.

 

 

For further details:

Fusionex

Ivan Teh, Chief Executive Officer

Yuen Choong Lai, Chief Financial Officer

 

Through Buchanan

 

Panmure Gordon

Fred Walsh, Grishma Patel, Ben Roberts (Investment Banking)

Tom Nicholson, Charles Leigh-Pemberton (Corporate Broking)

020 7886 2500

Buchanan

Jeremy Garcia, Gabriella Clinkard

www.buchanan.uk.com

020 7466 5000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSOVROBARRAA
Date   Source Headline
28th Jan 20169:55 amRNSDirector's Share Dealing
28th Jan 20167:00 amRNSDirector's Share Dealing
26th Jan 201611:43 amRNSDirector's Share Dealing
22nd Jan 20167:30 amRNSStatement in response to share price movement
21st Jan 20167:00 amRNSPreliminary results
18th Jan 20167:00 amRNSMillion dollar Open Data contract win
13th Jan 20167:00 amRNSGIANT contract win with Asian hospital
12th Jan 201610:00 amRNSNotification of Full Year Results
1st Dec 201510:22 amRNSNotification of Major Interest in Shares
1st Dec 20157:00 amRNSGIANT Contract Win
13th Nov 20157:00 amRNSDell & Fusionex Enter Into a GIANT Partnership
15th Oct 20157:01 amRNSPlacing
15th Oct 20157:00 amRNSTrading Update
29th Sep 20154:31 pmRNSTransfer of Shares
24th Jun 20157:00 amRNSGIANT Contract Win with Takaful Insurance
27th May 20157:00 amRNSInterim Results
18th May 20157:00 amRNSGIANT Contract Win with Brother Industries
12th May 20157:01 amRNSNotification of Interim Results Results
5th May 20157:01 amRNSNew GIANT Partnership
30th Apr 20157:00 amRNSTrading Update
24th Mar 20157:00 amRNSGIANT Contract Win
18th Mar 20157:00 amRNSAppointment of Joint Broker
6th Mar 201512:38 pmRNSResult of AGM
11th Feb 20157:00 amRNSDividend Declaration
10th Feb 20157:00 amRNSPosting of Annual Report
5th Feb 20157:00 amRNSPreliminary results
13th Jan 20157:00 amRNSNotification of Full Year Results
18th Nov 20147:00 amRNSCapital Markets Day
31st Oct 201410:43 amRNSNotification of Capital Markets Day
24th Oct 201412:26 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13th Oct 20147:00 amRNSTrading Update
11th Sep 20147:30 amRNSDouble Awards
6th Aug 20141:30 pmRNSAIM Disclosure Update
24th Jun 20147:00 amRNSTechnology Alliance
23rd May 20144:25 pmRNSDirector's Share Dealing
21st May 20147:00 amRNSInterim Results
28th Apr 20147:00 amRNSTrading Update
17th Mar 20147:00 amRNSRevolution Analytics partnership
11th Mar 20147:00 amRNSFusionex secures further GIANT contract wins
10th Mar 20147:00 amRNSAGM Statement
11th Feb 20147:00 amRNSPosting of Annual Report
29th Jan 20147:00 amRNSFusionex secures first 'GIANT' contract win
28th Jan 20147:00 amRNSDividend Declaration
15th Jan 20147:00 amRNSPreliminary results
8th Jan 20147:00 amRNSNotification of Full Year Results
11th Dec 20137:00 amRNSProduct launch
6th Dec 20137:00 amRNSFusionex Wins Award
7th Oct 20137:00 amRNSTrading Update
13th Aug 20137:00 amRNSMicrosoft Business Intelligence Award
21st May 20137:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.